Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)
Abstract
We present the preliminary neuropathologic criteria for progressive supranuclear palsy (PSP) as proposed at a workshop held at the National Institutes of Health, Bethesda, MD, April 24 and 25, 1993. The criteria distinguish typical, atypical, and combined PSP. A semiquantitative distribution of neurofibrillary tangles is the basis for the diagnosis of PSP. A high density of neurofibrillary tangles and neuropil threads in the basal ganglia and brainstem is crucial for the diagnosis of typical PSP. Tau-positive astrocytes or their processes in areas of involvement help to confirm the diagnosis. Atypical cases of PSP are variants in which the severity or distribution of abnormalities deviates from the typical pattern. Criteria excluding the diagnosis of typical and atypical PSP are large or numerous infarcts, marked diffuse or focal atrophy, Lewy bodies, changes diagnostic of Alzheimer's disease, oligodendroglial argyrophilic inclusions, Pick bodies, diffuse spongiosis, and prion protein-positive amyloid plaques. The diagnosis of combined PSP is proposed when other neurologic disorders exist concomitantly with PSP.
Get full access to this article
View all available purchase options and get full access to this article.
Information & Authors
Information
Published In
Neurology®
Volume 44 • Number 11 • November 1994
Pages: 2015
Copyright
© 1994 by the American Academy of Neurology.
Publication History
Published online: November 1, 1994
Published in print: November 1994
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Difficulties in diagnosing progressive supranuclear palsy, Russian neurological journal, 28, 2, (66-72), (2023).https://doi.org/10.30629/2658-7947-2023-28-2-66-72
- Brain aconitase activity is not decreased in progressive supranuclear palsy, Neurology, 59, 1, (137-138), (2023)./doi/10.1212/WNL.59.1.137
- Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease, Neurology, 57, 8, (1497-1499), (2023)./doi/10.1212/WNL.57.8.1497
- Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese , Neurology, 55, 6, (800-805), (2023)./doi/10.1212/WNL.55.6.800
- The tau gene A0 allele and progressive supranuclear palsy, Neurology, 53, 6, (1219-1219), (2023)./doi/10.1212/WNL.53.6.1219
- Clinicoradiologic and Neuropathologic Evaluation of Corticobasal Syndrome, Neurology, 101, 3, (e289-e299), (2023)./doi/10.1212/WNL.0000000000207397
- Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension, Neurology, 93, 14, (e1339-e1347), (2023)./doi/10.1212/WNL.0000000000008197
- Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration, Neurology, 92, 21, (e2472-e2482), (2023)./doi/10.1212/WNL.0000000000007530
- [11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy, Neurology, 90, 22, (e1989-e1996), (2023)./doi/10.1212/WNL.0000000000005610
- Frontal presentation in progressive supranuclear palsy, Neurology, 69, 8, (723-729), (2023)./doi/10.1212/01.wnl.0000267643.24870.26
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to get full access to it.